Aktienanalyse zu National Research Corp (NRC)NRCNational Research Corp

NRC Health, formerly National Research Corporation, provides healthcare experience improvement solutions. The Company is focused on improving the challenged healthcare ecosystem with stakeholder experience insights, market intelligence data, and software tools that enable health systems to improve patient outcomes and hospital operations. Its solutions consist of four solution categories: Patient Experience, Consumer Experience, Employee Experience, and Market Experience. The Company's portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. It operates in the Industrials sector (SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH industry).

National Research Corp (NRC) appears to be a good buy right now due to its current price of $21.85, which is below the analyst price target of $26, indicating a potential upside of approximately 19%. Additionally, the company has shown a solid year-to-date change of +21.19% and a one-year change of +44.99%, reflecting strong growth momentum. However, the main risk is the recent negative net income reported for Q2 2026, which was -3283000 USD, indicating potential volatility in earnings.